Vouhé P R, Tamisier D, Sidi D, Vernant F, Mauriat P, Pouard P, Leca F
Department of Cardiovascular Surgery, Laënnec Hospital, Paris, Frnce.
Ann Thorac Surg. 1992 Oct;54(4):621-6; discussion 627. doi: 10.1016/0003-4975(92)91004-s.
Thirty-one consecutive children with anomalous left coronary artery underwent direct aortic reimplantation of the anomalous artery without an associated procedure. There were five deaths (16%; 70% confidence limits, 9% to 26%), three in the hospital and two early (within 3 months). The severity of preoperative left ventricular dysfunction was the only incremental risk factor for mortality: 31% mortality rate among patients with left ventricular shortening fraction of less than 0.20 versus 0% among patients with a left ventricular shortening fraction of 0.20 or more (p = 0.03). There were no late deaths up to 6 years, a survival rate of 84% +/- 7%. Late results were studied in 23 survivors having a follow-up of longer than 12 months. Ninety-six percent were free of symptoms; left ventricular function recovered to normal in all patients; moderate to severe mitral regurgitation decreased to minimal or no regurgitation in most patients (5/7); and the reimplanted anomalous left coronary artery was patent in each patient. Based on this study, we reached five conclusions. (1) Direct aortic reimplantation is technically feasible in most patients with anomalous left coronary artery and yields a high rate of late patency. (2) Left ventricular resection is unnecessary. (3) The mitral valve should not be interfered with at the initial operation, but mitral regurgitation may persist in a few patients and necessitate later operation. (4) In patients with moderate left ventricular dysfunction, the operative risk is low and early operation indicated. (5) In patients with severe left ventricular dysfunction, the operative risk is high; heart transplantation may be suggested, but our current approach favors an immediate corrective procedure.
31例连续性左冠状动脉异常患儿接受了异常动脉直接主动脉再植入术,未进行相关联合手术。有5例死亡(16%;70%可信区间,9%至26%),3例于住院期间死亡,2例早期(3个月内)死亡。术前左心室功能障碍的严重程度是唯一增加死亡风险的因素:左心室缩短分数小于0.20的患者死亡率为31%,而左心室缩短分数为0.20或更高的患者死亡率为0%(p = 0.03)。至6年时无晚期死亡病例,生存率为84%±7%。对23例随访超过12个月的幸存者进行了晚期结果研究。96%无症状;所有患者左心室功能恢复正常;大多数患者(5/7)中、重度二尖瓣反流减轻至轻度反流或无反流;再植入的异常左冠状动脉在每位患者中均通畅。基于本研究,我们得出了五条结论。(1)对于大多数左冠状动脉异常患者,直接主动脉再植入术在技术上是可行的,且晚期通畅率高。(续)(2)无需进行左心室切除术。(3)初次手术时不应干预二尖瓣,但少数患者的二尖瓣反流可能持续存在,需要二期手术。(4)对于左心室功能中度障碍的患者,手术风险低,建议早期手术。(5)对于左心室功能严重障碍的患者,手术风险高;可考虑心脏移植,但我们目前的方法倾向于立即进行矫正手术。